KF

Keegan Flowers

PET Radiopharmaceutical Specialist at Life Molecular Imaging

Keegan Flowers has extensive experience in the field of radiopharmaceuticals and quality control, currently serving as a PET Radiopharmaceutical Specialist at Life Molecular Imaging since August 2022. Prior roles include Advanced Application Specialist at GE Healthcare and various positions at SOFIE, where responsibilities ranged from radiopharmaceutical contract manufacturing management to product development. Keegan has a strong background in laboratory management and quality control, evident from managing operations at CRCHUM and serving as a Radiochemistry Technologist at the University of Ottawa Heart Institute. Educational credentials include a Bachelor's Degree in Biochemistry from Bishop's University, complemented by diverse roles in research and teaching.

Location

Lake Mary, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Life Molecular Imaging

Life Molecular Imaging (formerly Piramal Imaging) is now part of the Alliance Medical Group, an integrated business including research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities. These combined services allow physicians, pharma industry and academia greater access to established and innovative imaging agents for clinical trials and clinical routine. With an ever increasing demand of effective care as well as a growing global awareness of healthcare efficiency and costs, improved diagnostic tools offer a unique opportunity for: - Earlier detection and better characterization of diseases - Determining the right therapy at the right dose for a patient (precision medicine) - Monitoring therapy response As a global leader in the field of radiopharmaceuticals, Life Molecular Imaging is developing a product portfolio of innovative molecular imaging probes that address major clinical needs in neurology, oncology, and cardiology. Life Molecular Imaging is supporting use of imaging biomarkers in several major therapeutic trials in Alzheimer’s disease. Imprint: Life Molecular Imaging GmbH Tegeler Strasse 6-7 13353 Berlin Germany Telefon: +49 30 461 124603 Fax: +49 30 461 124 629 Email: info@life-mi.com Internet: http://www.life-mi.com Managing Directors: Dr. Ludger Dinkelborg Michel Jongens Chamber of Commerce: Amtsgericht Charlottenburg HRB 136823 B Sales tax identification number: DE 283685037 Data Protection Policy: https://life-mi.com/data-protection/


Employees

51-200

Links